Increasing Access through Intentional Trial Designs

11:20 AM - 12:30 PM (EDT), Tuesday, November 19, 2024
How do we design trials that people want to and are able to participate in? What are effective trial design elements and features, and strategies for conducting trials at non-traditional sites (e.g., private practices, community clinics) and mitigating time and financial burdens for participants through compensation?
Moderator
Director, US R&D and Regulatory Policy
BioMarin Pharmaceutical, Inc.
Speakers
Associate Professor of Medicine
Howard University College of Medicine
Medical Director, Clinical Development, Alzheimer’s & Dementia Unit
Biogen
Associate Director for Cancer in Older Adults
OCE, FDA
Vice President of Patient Engagement
Precision for Medicine
Founder & CEO
WSCollaborative